1. Stocks
  2. Windlas Biotech Ltd.
  3. Swot
swot-logo

Windlas Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Windlas Biotech Ltd. has 22 Strengths, 4 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing Revenue every Quarter for the past 8 Quarters

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

FII / FPI or Institutions increasing their shareholding

Weekly Momentum Gainers

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks